Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Grabowski

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
The Journal of Biological Chemistry|February 6, 2003
Phosphorylation of serine 1106 in the catalytic domain of topoisomerase II alpha regulates enzymatic activity and drug sensitivityKenichi Chikamori, Dale R Grabowski, Michael Kinter, et al.
Molecular Cancer Therapeutics|December 24, 2005
Sensitization of DNA damage-induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3sigma and survivinSusan A J Vaziri, Jason Hill, Kenichi Chikamori, et al.
Nucleic Acids Research|May 5, 2017
Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpointToshiyuki Kozuki, Kenichi Chikamori, Marius D Surleac, et al.
Leukemia|August 26, 2006
Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrestK Chikamori, J E Hill, D R Grabowski, et al.
The Journal of Clinical Investigation|January 27, 2022
Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemiaYihong Guan, Metis Hasipek, Dongxu Jiang, et al.
Blood Cancer Discovery|March 8, 2021
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid NeoplasmsYihong Guan, Anand D Tiwari, James G Phillips, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
The Journal of Biological Chemistry|February 6, 2003
Phosphorylation of serine 1106 in the catalytic domain of topoisomerase II alpha regulates enzymatic activity and drug sensitivityKenichi Chikamori, Dale R Grabowski, Michael Kinter, et al.
Molecular Cancer Therapeutics|December 24, 2005
Sensitization of DNA damage-induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3sigma and survivinSusan A J Vaziri, Jason Hill, Kenichi Chikamori, et al.
Nucleic Acids Research|May 5, 2017
Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpointToshiyuki Kozuki, Kenichi Chikamori, Marius D Surleac, et al.
Leukemia|August 26, 2006
Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrestK Chikamori, J E Hill, D R Grabowski, et al.
The Journal of Clinical Investigation|January 27, 2022
Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemiaYihong Guan, Metis Hasipek, Dongxu Jiang, et al.
Blood Cancer Discovery|March 8, 2021
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid NeoplasmsYihong Guan, Anand D Tiwari, James G Phillips, et al.
Pageof 9